Increasing Breast Cancer Incidence Driving Market Demand
The Breast Biopsy Market is witnessing heightened demand as global breast cancer incidence rises. According to MRFR, early diagnosis is crucial for improving survival rates, which is prompting healthcare systems to invest in advanced biopsy devices and training. Rising public health campaigns, government-led screening initiatives, and growing insurance coverage for diagnostic procedures are all catalyzing market growth. Moreover, collaborations between device manufacturers and oncology networks are expanding biopsy availability, ensuring timely detection in both urban and rural settings.